Multilateral initiative on malaria: justification, evolution, achievements, challenges, opportunities, and future plans.
Malaria is a major public health problem; about half of the world's populations live under exposure. The problem is increasing in magnitude and complexity because it is entwined with low socio-economic status, which makes African women and children particularly vulnerable. Combating malaria therefore requires concerted international efforts with an emphasis on Africa. The Multilateral Initiative on Malaria (MIM) was founded in 1997 to meet that need through strengthening research capacity in Africa, increasing international cooperation and communication, and utilization of research findings to inform malaria prevention, treatment, and control. The review undertaken in 2002 showed that through improved communication and science-focused institutional networks, MIM had brought African scientists together, opened up communication among malaria stakeholders, and provided Internet access to literature. The achievements were made through four autonomous constituents including the coordinating Secretariat being hosted for the first time in Africa by the African Malaria Network Trust (AMANET) for the period 2006-2010. The other constituents are the MIM TDR providing funding for peer-reviewed research; MIMCom facilitating Internet connectivity, access to medical literature, and communication between scientists inside and outside of Africa; and MR4 providing scientists access to research tools, standardized reagents, and protocols. Future plans will mostly consolidate the gains made under the MIM Strategic Plan for the period 2003-2005.
Rugemalila
Joas B
JB
Multilateral Initiative on Malaria (MIM) Secretariat, Bagamoyo Highway, Dar es Salaam, Tanzania. joasrugemalila@gmail.com
Ogundahunsi
Olumide A T
OA
Stedman
Timothy T
TT
Kilama
Wen L
WL
D000349:Africa; D017281:Cost of Illness; D006801:Humans; D007391:International Cooperation; D008288:Malaria / Q000191:economics / Q000469:parasitology / Q000517:prevention & control / Q000628:therapy*; D012106:Research